仁度生物
(688193)
| 流通市值：9.55亿 | | | 总市值：12.62亿 |
| 流通股本：3025.76万 | | | 总股本：4000.00万 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 589,909,175.16 | 609,567,016.44 | 681,826,214.46 | 288,900,526.29 |
| 应收票据及应收账款 | 69,704,041.39 | 77,065,621.68 | 81,430,816 | 86,287,443.36 |
| 其中：应收票据 | 100,000 | 259,948.88 | - | - |
| 应收账款 | 69,604,041.39 | 76,805,672.8 | 81,430,816 | 86,287,443.36 |
| 应收款项融资 | 775,788 | 532,680 | 538,200 | 96,600 |
| 预付款项 | 3,535,859.85 | 2,640,583.03 | 3,088,226.8 | 2,482,646.37 |
| 其他应收款合计 | 957,669.44 | 1,100,926.34 | 1,586,496.34 | 1,203,975.69 |
| 其中:应收利息 | - | - | 300,458.33 | 24,449.3 |
| 存货 | 27,025,375.34 | 28,595,133.59 | 31,173,606.76 | 31,147,584.43 |
| 其他流动资产 | 155,289,654.87 | 129,429,149.4 | 3,721,688.06 | 4,257,672.82 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 887,218,897.39 | 899,141,593.82 | 934,008,498.43 | 936,006,827.57 |
| 非流动资产: | | | | |
| 固定资产 | 84,615,613.09 | 85,796,703.58 | 84,850,561.93 | 87,604,104.88 |
| 使用权资产 | 6,226,533.05 | 6,921,347.71 | 7,616,162.37 | 8,303,405.86 |
| 无形资产 | 401,568.94 | 449,885.35 | 488,701.64 | 546,518.06 |
| 长期待摊费用 | 7,814,054.87 | 8,298,077.41 | 7,511,523.82 | 7,682,453.2 |
| 递延所得税资产 | 13,336,729.33 | 12,958,033.21 | 12,690,574.56 | 12,334,041.18 |
| 其他非流动资产 | 41,211,665 | 41,150,055 | 549,600 | 791,718.58 |
| 非流动资产平衡项目 | 0 | 0 | 0.01 | 0.01 |
| 非流动资产合计 | 153,606,164.28 | 155,574,102.26 | 113,707,124.33 | 117,262,241.77 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,040,825,061.67 | 1,054,715,696.08 | 1,047,715,622.76 | 1,053,269,069.34 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 3,905,214.08 | 4,093,721.67 | 5,580,904.9 | 5,821,654.48 |
| 应付账款 | 3,905,214.08 | 4,093,721.67 | 5,580,904.9 | 5,821,654.48 |
| 合同负债 | 3,994,282.14 | 5,576,662.23 | 4,407,616.17 | 4,505,674.52 |
| 应付职工薪酬 | 8,343,554.83 | 12,893,327.03 | 9,649,507.41 | 10,266,011.11 |
| 应交税费 | 1,794,321.93 | 1,547,366.74 | 1,121,717.85 | 928,322.29 |
| 其他应付款合计 | 51,876,772.77 | 51,278,886.38 | 43,902,901.65 | 49,785,439.47 |
| 一年内到期的非流动负债 | 2,499,490.83 | 2,925,195.22 | 683,705.69 | 1,994,122.01 |
| 其他流动负债 | 147,413.51 | 131,793.74 | 173,167.7 | 141,937.71 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 72,561,050.09 | 78,446,953.01 | 65,519,521.37 | 73,443,161.59 |
| 非流动负债: | | | | |
| 租赁负债 | 3,878,617.7 | 4,090,994.16 | 7,008,707.51 | 6,006,684.93 |
| 预计负债 | - | 11,800.78 | 4,672.87 | 25,792.62 |
| 递延收益 | 8,317,209.26 | 9,424,306.64 | 22,664,400 | 22,664,400 |
| 递延所得税负债 | - | - | 1,198,062.49 | 1,346,131.78 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 12,195,826.96 | 13,527,101.58 | 30,875,842.87 | 30,043,009.33 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 84,756,877.05 | 91,974,054.59 | 96,395,364.24 | 103,486,170.92 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 40,000,000 | 40,000,000 | 40,000,000 | 40,000,000 |
| 资本公积 | 774,961,635.3 | 773,701,406.86 | 778,301,168.27 | 778,301,168.27 |
| 减:库存股 | 11,706,268.91 | - | - | - |
| 其他综合收益 | -279,926.95 | -348,602.73 | 232,777.99 | 544,822.64 |
| 盈余公积 | 12,924,505.3 | 12,924,505.3 | 11,377,280.8 | 11,377,280.8 |
| 未分配利润 | 140,168,239.88 | 136,464,332.06 | 121,409,031.46 | 119,559,626.71 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 956,068,184.62 | 962,741,641.49 | 951,320,258.52 | 949,782,898.42 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 956,068,184.62 | 962,741,641.49 | 951,320,258.52 | 949,782,898.42 |
| 负债和股东权益合计 | 1,040,825,061.67 | 1,054,715,696.08 | 1,047,715,622.76 | 1,053,269,069.34 |
| 公告日期 | 2024-04-30 | 2024-04-30 | 2023-10-31 | 2023-08-01 |
| 审计意见(境内) | | 标准无保留意见 | | |